Krazati
MIRATI THERAPEU
Indication Removed: Colorectal cancer with KRAS G12C mutation.
Drug Changes
Review recent approvals, biosimilar updates, dosing changes, indications, pronunciation updates, and more.
7 changes from the current 90-day window.
MIRATI THERAPEU
Indication Removed: Colorectal cancer with KRAS G12C mutation.
EUGIA US LLC
Indication Removed: EGFR negative, ALK negative, non-small cell lung cancer.